Table 1 Description of Criminal Justice-involved Studies from STTR Cohort [10]

CARE + RCT

RCT of CARE+ Corrections intervention; Washington, DC

Aged 18+; HIV-infected; released from the correctional facility or half-way house ≤6 months ago and living in Washington, DC metropolitan community (not a restricted setting, e.g. half-way house) or currently detained in jail with anticipated release to community (not a restricted setting); reading at 8th grade level and English-speaking.

IMPACT

RCT of imPACT intervention vs. standard of care; NC and TX prisons

Aged 18+; HIV-infected with HIV RNA < 400 copies/mL receiving ART who were incarcerated in NC or TX and 3 months prior to release and not convicted of sexual assault, death or serious injury; English-speaking.

LINK LA

RCT of intervention; Los Angeles County Jails, CA

Men and transgender women, aged 18+; HIV-infected; eligible for ART, or on ART; jailed for 5+ days, being released to community; residing in Los Angeles County, CA upon release; English or bilingual Spanish speaking.

NEW HOPE

Double Blind Placebo-controlled RCT of extended-release naltrexone; New Haven, Hartford, Waterbury, CT or Springfield, MA

Aged 18+, HIV-infected, meeting DSM-IV criteria for opioid dependence, within CT & Springfield, MA corrections system and not pending trial for a felony, within 30 days of being released to greater New Haven, Hartford, Waterbury or Springfield areas or 30 days after release; English- or Spanish-speaking, no liver failure or grade IV hepatitis, no active opioid withdrawal, no receipt of methadone or buprenorphine/naloxone for treatment of opioid dependency, no participation in pharmacotherapy trial in the previous 30 days

STRIDE1

RCT of buprenorphine vs. placebo; Washington, DC

Aged 18+; HIV-infected; meeting DSM-IV criteria for opioid dependence; resident of Washington, DC with eligibility for medical entitlements; English- or Spanish-speaking; no current opiate medications for chronic pain conditions or need to be placed on such medications; no current methadone doses over 30 mg/day, no AST and ALT >5x the ULN; no pregnancy or breast-feeding; no liver dysfunction; no suicidal ideation; no participation in pharmacotherapy trial in the previous 30 days.

STRIDE2

Longitudinal cohort study comparing treatment using opioid substitution therapy to no treatment; Washington, DC

Aged 18+; HIV-infected; meeting DSM-IV criteria for opioid dependence; resident of Washington DC with eligibility for medical entitlements; English-speaking.

SUCCESS

Non-randomized pilot study of Strengths-Based case management; Atlanta, GA Jails

Aged 18+; HIV-infected; detained or sentenced in jail or detention center and likely to leave within 6 weeks; no recent participation in randomized trial to improve retention in HIV care; English-speaking.